The size of the global dialysis market is estimated to be worth USD 157.29 billion by 2027 from USD 106.26 billion in 2022, registering a CAGR of 8.16% during the forecast period.
Y-O-Y growth in the incidence of kidney failure and ESRD is primarily accelerating the growth of the dialysis market across the world.
The prevalence of kidney failure and end-stage renal disease (ESRD) has exploded in intensive care units in hospitals around the world, creating a worrying shortage of dialysis machines and even dialysis solutions. The disease is spreading rapidly in more than 99 countries around the world. Worldwide, approximately 2 million people are affected by ESRD each year. The growing geriatric population is increasing the number of older people with chronic illnesses who suffer from complications that can include kidney problems. According to a 2020 annual report from the US Kidney Data System, Taiwan and Malaysia have the highest incidence of treated ESRD in the 45 to 65 age group and in the 75 and over age group. Due to the increase in the number of patients, local government authorities have increased the number of dialysis centers provided by public or private funds. The prevalence of chronic kidney disease (CKD) and increased life expectancy will continue to drive the market demand for dialysis. Another factor influencing the growth of the market is the expansion of health infrastructure in all countries.
Supportive government initiatives and increased awareness of kidney disorders and their treatment modalities are also expected to drive the market during the forecast period. The evolution of technologically advanced dialysis equipment and therefore kidney dialysis are key factors impacting the dialysis market. Increased awareness of kidney problems and the types of treatments decreased complications. An increasing number of dialysis centers and hospitals in developing countries, combined with an increasing number of patient treatments, is expected to drive the evolution of new dialysis equipment to drive the dialysis market during the period of forecast.
Easy US FDA approval for the clinical trial of the dialysis systems will give better opportunities for the dialysis market. The latest dialysis system provides a good platform for patients to do dialysis at home. Many companies are aiming to make the devices customer-friendly. Other factors such as new funding channels in the health sector, better health care infrastructure, the increase in the number of dialysis patients, and the adoption of advanced technologies in the field of dialysis are important factors that are expected to help the dialysis market.
Factors such as strict local government regulations, frequent product recalls, and the inability of new products to reach deeper markets are predicted to limit the global dialysis market growth during the forecast period.
The high price of dialysis treatment and devices is the biggest restriction on the market. Furthermore, the lack of awareness of kidney disease is hampering the growth rate of the market, coupled with an extremely competitive market for small to medium-sized enterprises, which will restrain the growth of the market. In addition, factors such as poor knowledge of kidney disease treatment, decreased medical reimbursement for dialysis treatments, high costs associated with the technology, and various risks of complications and risks associated with dialysis will hamper the rate of growth of the market. Most dialysis devices are complex systems that are difficult to understand easily by patients. This is the biggest challenge in the market and it can only be met by training and the introduction of ease of accessibility in the equipment.
COVID-19 Impact on the global dialysis market:
The growing burden of acute kidney injury (AKI) associated with COVID-19 is increasing as the number of older people infected with the virus spreads. At the start of the pandemic, AKI's COVID-19 risk was estimated to be a minimum of 2.3% to 9.1%. Currently, incidence rates have increased by over 18.5%, which focused on the management of kidney failure in patients with COVID. -19 plus respiratory failure. People on dialysis are required to visit clinics or hospitals 2-3 times a week, where there are concerns that patients may be infected with the coronavirus. With the spread of the COVID-19 virus, home dialysis devices are in more demand among patients. Hence, the growth rate of the dialysis market is growing for the next few years.
Market Size Available
2021 to 2027
2022 to 2027
By Type, Dialysis, End-User & Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
This research report on the global dialysis market has been segmented and sub-segmented based on type, dialysis, End-User, and region.
Global Dialysis Market - By Type:
Based on the type, the services segment accounted for the largest share of the dialysis market. The segment growth is attributed to the increased focus on quality care delivery to patients by service providers and the establishment of well-equipped renal care facilities for chronic and acute treatment around the world. Furthermore, service providers enhanced business models, which are patient-centric and profit-driven, are increasing demand for services.
Global Dialysis Market - By Dialysis Type
Based on the dialysis type, the hemodialysis recorded the significant and is predicted to continue its growth throughout the forecast period. Inadequate peritoneal treatment training in both developed and developing nations has limited the preference for peritoneal treatment.
Global Dialysis Market - By End User
Based on the end-user, the Dialysis treatment centers accounted for the largest market share in terms of value, which can be due to advantageous reimbursement offered by renal institutions and hospitals for renal therapies, a growing patient pool suffering from CKD and ESRD, and rising population healthcare spending.
Global Dialysis Market - By Region
Geographically, The North American dialysis market is anticipated to grow at a CAGR of 7.5% during the forecast period and is predicted to account for the most significant share in the global market from 2021 to 2026. Factors such as a large number of patients and well-developed healthcare infrastructure are expected to generate good revenues in the region. Canada will also experience healthy growth in the CAGR due to the growing incidence of kidney diabetes and obesity in the country. The boom in public health care spending in Canada should open a new development path for the Canadian dialysis market.
The dialysis market in Europe is estimated to witness a prominent CAGR during the forecast period. In Europe, the German dialysis market is expected to grow by a CAGR of around 4.9%. The European market is expected to experience lucrative market growth due to increased research spending, technological advancements, deteriorating human health, and the need for innovative and effective therapies. The increasing rate of kidney disease among the UK population is increasing the growth of the dialysis market in Europe.
The dialysis market in the Middle East and Africa is estimated to account for a moderate share in the global market during the forecast period. The size of the South African dialysis market is expected to reach USD 2 billion by 2026. The increasing incidence of end-stage renal disease (ESRD) is expected to drive the market at a CAGR of 5% during the period of forecast. In developing African countries, only 22% of patients receive dialysis treatment.
Reimbursement is essential for the greater acceptability of dialysis due to the high cost of treatment. As a result, most patients in emerging countries in the MEA region either drop out of treatment midway or do not have access to treatment due to financial constraints. Supportive government initiatives will help develop the market in Latin America. The United Nations projects that the proportion of the Latin American population aged 65 and over will triple by the middle of the century, from 6.5% in 2005 to 21.5% in 2055. Brazil is expected to dominate the market dialysis in Latin America during the projected period.
KEY MARKET PARTICIPANTS:
A few of the notable players operating in the global dialysis market profiled in this report are Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Diaverum Healthcare Partners, Medtronic, Asahi Kasei Corporation and Nipro Corporation.
RECENT MARKET DEVELOPMENTS:
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferences
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquisition Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 Global Dialysis Market, By Type
6.3.1 Market Size Estimations & Forecasts (2022 - 2027)
6.3.2 Y-o-Y Growth Rate Analysis
6.3.3 Market Attractiveness Index
6.4 Global Dialysis Market, By Dialysis Type
6.6 Peritoneal Dialysis
6.6.1 Market Size Estimations & Forecasts (2022 - 2027)
6.6.2 Y-o-Y Growth Rate Analysis
6.6.3 Market Attractiveness Index
6.7 Global Dialysis Market, By End User
6.8 Dialysis Centres & Hospitals
6.9 Home Care
6.9.1 Market Size Estimations & Forecasts (2022 - 2027)
6.9.2 Y-o-Y Growth Rate Analysis
6.9.3 Market Attractiveness Index
7. Geographical Landscape
7.1 Global Identity Governance and Administration Market, by Region
7.2 North America - Market Analysis (2022 - 2027)
7.2.1 By Country
7.2.2 By Type
7.2.3 By Dialysis Type
7.2.4 By End User
7.3.1 By Country
184.108.40.206 Rest of Europe
7.3.2 By Type
7.3.3 By Dialysis Type
7.3.4 By End User
7.4 Asia Pacific
7.4.1 By Country
220.127.116.11 South Korea
18.104.22.168 South East Asia
22.214.171.124 Australia & NZ
126.96.36.199 Rest of Asia-Pacific
7.4.2 By Type
7.4.3 By Dialysis Type
7.4.4 By End User
7.5 Latin America
7.5.1 By Country
188.8.131.52 Rest of Latin America
7.5.2 By Type
7.5.3 By Dialysis Type
7.5.4 By End User
7.6 Middle East and Africa
7.6.1 By Country
184.108.40.206 Middle East
7.6.2 By Type
7.6.3 By Dialysis Type
7.6.4 By End User
8. Key Player Analysis
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Fresenius Medical Care AG & Co.
8.4 DaVita Healthcare Partners, Inc.
8.5 B. Braun Melsungen AG
8.6 Baxter International, Inc.
8.8 Dickinson and Company
8.9 Diaverum Healthcare Partners
8.11 Asahi Kasei Corporation and Nipro Corporation
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures
The global dialysis market is growing at a healthy pace and is predicted to be worth USD 157.29 billion by 2027.
Based on type, the services segment dominated the global dialysis market in 2021.
Based on the dialysis type, the hemodialysis segment dominated the market in 2021 and is forecasted to register the fastest growth from 2022 to 2027.
Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Diaverum Healthcare Partners, Medtronic, Asahi Kasei Corporation and Nipro Corporation are some of the major companies in the global dialysis market.
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.